- Home
- ASPC vs SERA Comparison
ASPC vs SERA Comparison
Compare ASPC & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPC
- SERA
- Stock Information
- Founded
- ASPC 2024
- SERA 2008
- Country
- ASPC Hong Kong
- SERA United States
- Employees
- ASPC N/A
- SERA N/A
- Industry
- ASPC
- SERA Precision Instruments
- Sector
- ASPC
- SERA Health Care
- Exchange
- ASPC Nasdaq
- SERA Nasdaq
- Market Cap
- ASPC 82.3M
- SERA 87.4M
- IPO Year
- ASPC 2024
- SERA 2021
- Fundamental
- Price
- ASPC $10.17
- SERA $1.58
- Analyst Decision
- ASPC
- SERA
- Analyst Count
- ASPC 0
- SERA 0
- Target Price
- ASPC N/A
- SERA N/A
- AVG Volume (30 Days)
- ASPC 11.0K
- SERA 240.9K
- Earning Date
- ASPC 01-01-0001
- SERA 05-07-2025
- Dividend Yield
- ASPC N/A
- SERA N/A
- EPS Growth
- ASPC N/A
- SERA N/A
- EPS
- ASPC 0.05
- SERA N/A
- Revenue
- ASPC N/A
- SERA $115,000.00
- Revenue This Year
- ASPC N/A
- SERA $390.13
- Revenue Next Year
- ASPC N/A
- SERA $440.54
- P/E Ratio
- ASPC $218.81
- SERA N/A
- Revenue Growth
- ASPC N/A
- SERA N/A
- 52 Week Low
- ASPC $9.95
- SERA $1.53
- 52 Week High
- ASPC $10.51
- SERA $9.53
- Technical
- Relative Strength Index (RSI)
- ASPC N/A
- SERA 20.44
- Support Level
- ASPC N/A
- SERA $2.22
- Resistance Level
- ASPC N/A
- SERA $2.47
- Average True Range (ATR)
- ASPC 0.00
- SERA 0.18
- MACD
- ASPC 0.00
- SERA -0.02
- Stochastic Oscillator
- ASPC 0.00
- SERA 5.11
About ASPC A SPAC III Acquisition Corp. Class A Ordinary Shares
A SPAC III Acquisition Corp is a blank check company.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.